Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies

Forum Kamdar1, Andre Klaassen Kamdar1, Naoko Koyano-Nakagawa1

  • 1Cardiovascular Division and Lillehei Heart Institute, University of Minnesota, Minneapolis, Minnesota.

Insights

Patient-specific induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a powerful "disease in a dish" model. These hiPSC-CMs help unravel the complex molecular mechanisms underlying inherited cardiomyopathies.

Area of Science:

  • Cardiovascular Medicine
  • Stem Cell Biology
  • Genetics

Background:

  • Inherited cardiomyopathies are genetically defined cardiovascular diseases.
  • Understanding their molecular mechanisms is crucial but challenging.
  • Traditional models have limitations in recapitulating human disease.

Purpose of the Study:

  • To review the application of patient-specific human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (CMs) for in vitro modeling of inherited cardiomyopathies.
  • To highlight the potential of hiPSC-CMs as a "disease in a dish" model.
  • To provide an overview of current research in this field.

Main Methods:

  • Generation of patient-specific hiPSC-derived cardiomyocytes (CMs).
  • Maintenance of hiPSC-CMs in cell culture.
  • Characterization of disease phenotypes in vitro using hiPSC-CMs.

Main Results:

  • hiPSC-derived CMs retain the patient's genetic blueprint.
  • These cells recapitulate the phenotypic characteristics of inherited cardiomyopathies in vitro.
  • This technology enables the study of disease mechanisms in a patient-specific manner.

Conclusions:

  • Patient-specific hiPSC-derived CMs are a valuable tool for studying inherited cardiomyopathies.
  • This in vitro modeling approach advances our understanding of cardiovascular disease mechanisms.
  • hiPSC-CMs hold promise for future therapeutic development.